Business
Eiko Lifesciences Limited Press Release Aug 13 2026
Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, The copy of newspaper publication in the following newspapers dated 13th August, 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter ended 30th June, 2026 approved at the meeting of Board of Directors held on Wednesday, 12th August, 2026, is attached herewith. 1. Financial Express (English)2. Mumbai Lakshadeep (Marathi)
About this update from Eiko Lifesciences Limited
Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, The copy of newspaper publication in the following newspapers dated 13th August, 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter ended 30th June, 2026 approved at the meeting of Board of Directors held on Wednesday, 12th August, 2026, is attached herewith. 1. Financial Express (English)2. Mumbai Lakshadeep (Marathi) View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited